Literature DB >> 9463678

Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin.

J Gardon1, J Kamgno, G Folefack, N Gardon-Wendel, B Bouchité, M Boussinesq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9463678     DOI： 10.1016/s0035-9203(97)90041-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  19 in total

1.  Potential Role for Flubendazole in Limiting Filariasis Transmission: Observations of Microfilarial Sensitivity.

Authors:  Maeghan O'Neill; Jelil Abdel Njouendou; Michael Dzimianski; Erica Burkman; Patrick Chouna Ndongmo; Jonas A Kengne-Ouafo; Samuel Wanji; Andrew Moorhead; Charles D Mackenzie; Timothy G Geary
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

2.  Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.

Authors:  Joseph Kamgno; Hugues C Nana-Djeunga; Sébastien D Pion; Cédric B Chesnais; Amy D Klion; Charles D Mackenzie; Thomas B Nutman; Michel Boussinesq
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

3.  Case report: Loiasis with peripheral nerve involvement and spleen lesions.

Authors:  Federico Gobbi; Michel Boussinesq; Marta Mascarello; Andrea Angheben; Maria Gobbo; Andrea Rossanese; Manuel Corachán; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

4.  A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy.

Authors:  Tuna Lukiana; Madone Mandina; Nanituma H Situakibanza; Marcel M Mbula; Bompeka F Lepira; Wobin T Odio; Joseph Kamgno; Michel Boussinesq
Journal:  Filaria J       Date:  2006-05-10

5.  Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

Authors:  Michel Boussinesq; Jacques Gardon; Nathalie Gardon-Wendel; Jean-Philippe Chippaux
Journal:  Filaria J       Date:  2003-10-24

6.  Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.

Authors:  Nana AY Twum-Danso
Journal:  Filaria J       Date:  2003-10-24

7.  Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.

Authors:  Nana AY Twum-Danso
Journal:  Filaria J       Date:  2003-10-24

8.  Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.

Authors:  Sébastien Ds Pion; Hugues Nana-Djeunga; Yannick Niamsi-Emalio; Cédric B Chesnais; Hugo Deléglise; Charles Mackenzie; Wilma Stolk; Daniel A Fletcher; Amy D Klion; Thomas B Nutman; Michel Boussinesq; Joseph Kamgno
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 25.071

9.  Genome Filtering for New DNA Biomarkers of Loa loa Infection Suitable for Loop-Mediated Isothermal Amplification.

Authors:  Catherine B Poole; Laurence Ettwiller; Nathan A Tanner; Thomas C Evans; Samuel Wanji; Clotilde K S Carlow
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

10.  Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.

Authors:  Marc K Kouam; Jules B Tchatchueng-Mbougua; Maurice Demanou; Michel Boussinesq; Sébastien D S Pion; Joseph Kamgno
Journal:  Parasit Vectors       Date:  2013-09-27       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.